Only logged in users can watch the content

Chat keyboard_arrow_down
Description keyboard_arrow_down
Esophageal cancer remains one of the most prevalent cancers globally and a leading cause of cancer-related mortality. Among the various treatments available, three-field lymphadenectomy has recently gained significant attention. Originating in Japan in the 1980s and now utilized in several other countries, it continues to be a topic of active discussion, especially in the context of contemporary neoadjuvant treatments. This upcoming webinar will bridge Japanese and European perspectives on this critical topic. We will explore best practices and review evidence on reducing complications, providing valuable insights for surgeons worldwide.


  1. JSES Introduction

  2. Welcome & Introduction - Prof. Hiroya Takeuchi (Japan)

  3. JCOG1409 (MONET Trial)  - Prof. Hiroya Takeuchi (Japan)

  4. Precise Upper Mediastinal Dissection for Esophageal Cancer and Future Perspective of Three-Field Lymphadenectomy - Dr. Shigeru Tsunoda (Japan)

  5. Treatment of Anastomotic Leakage after Esophagectomy - Prof. Dr. Richard van Hillegersberg (Netherlands)

  6. Panel Discussion - All faculty moderated by Prof. Hiroya Takeuchi (Japan)

  7. Closing Remarks -  Prof. Hiroya Takeuchi (Japan)

Faculty keyboard_arrow_down
Prof. Hiroya Takeuchi MD, PhD, FACS, Professor and Chairman, Department of Surgery, Hamamatsu University School of Medicine, Japan Surgical Oncology
Dr. Shigeru Tsunoda MD, PhD, FACS, Junior Associate Professor, Department of Surgery, Graduate School of Medicine, Kyoto University; Director of Esophageal Cancer Unit, Kyoto University Cancer Center, Japan Gastroesophageal Surgery
Prof. Dr. Richard van Hillegersberg MD, PhD, Professor of Surgery and Consultant of Surgical Oncology, Department of Surgical Oncology, Cancer Center, University Medical Center Utrecht, Netherlands Surgical Oncology
Related Content keyboard_arrow_down